Healthcare provider profile · identity verified

Brienna M Cameron, PA-C

Physician Assistant · LYNNVILLE, IA · NPI 1669711925

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	304	60
Amlodipine Besylate	Amlodipine Besylate	179	34
Omeprazole	Omeprazole	143	32
Atorvastatin Calcium	Atorvastatin Calcium	137	39
Losartan Potassium	Losartan Potassium	119	35
Pantoprazole Sodium	Pantoprazole Sodium	113	18
Sertraline Hcl	Sertraline Hcl	92	19
Lisinopril	Lisinopril	86	22
Famotidine	Famotidine	83	17
Simvastatin	Simvastatin	83	19
Tamsulosin Hcl	Tamsulosin Hcl	67	14
Duloxetine Hcl	Duloxetine Hcl	62	13
Alendronate Sodium	Alendronate Sodium	59	18
Cefdinir	Cefdinir	56	47
Meloxicam	Meloxicam	53	12
Tramadol Hcl	Tramadol Hcl	52	17
Fluticasone Propionate	Fluticasone Propionate	51	27
Glimepiride	Glimepiride	50	suppressed
Alprazolam	Alprazolam	48	suppressed
Furosemide	Furosemide	47	15
Metformin Hcl Er	Metformin Hcl	43	suppressed
Atenolol	Atenolol	42	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	20
Glipizide Er	Glipizide	41	11
Pravastatin Sodium	Pravastatin Sodium	41	suppressed
Metformin Hcl	Metformin Hcl	40	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	38	11
Potassium Chloride	Potassium Chloride	38	suppressed
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Gabapentin	Gabapentin	37	11
Trazodone Hcl	Trazodone Hcl	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Metoprolol Succinate	Metoprolol Succinate	36	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	24
Azithromycin	Azithromycin	31	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Prednisone	Prednisone	27	21
Cephalexin	Cephalexin	26	21
Terazosin Hcl	Terazosin Hcl	26	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	26	suppressed
Eliquis	Apixaban	24	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	15
Jardiance	Empagliflozin	23	suppressed
Allopurinol	Allopurinol	21	suppressed
Carvedilol	Carvedilol	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	20	15
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	19	19
Bupropion Xl	Bupropion Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	17	suppressed
Ozempic	Semaglutide	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Naproxen	Naproxen	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Finasteride	Finasteride	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Avonex Pen (4 Pack)	Interferon Beta-1a	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Methylprednisolone	Methylprednisolone	13	11
Risperidone	Risperidone	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Nadolol	Nadolol	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error